Nghiên cứu về độ an toàn và hiệu quả của bóng thuốc phủ trong điều trị bệnh nhân nhồi máu cơ tim cấp tính

Stone GW, Witzenbichiler B, Guagliumiu G, Peruga JZ, Brodie BR, Dudek D, etc. In acute myocardial infarction (HORIZONS-AMI) Heparinplus glycoprotein IIb / herIIIa inhibitor and bivalirudin monotherapy, inhibitor and bivalirudin monotherapy, and paclitaxel-eluting stent and bar mental stent comparison: the final 3 years from A multicenter, randomized controlled trial. Lancet. 2011;377:2193-204. Luca GD, Suryapranata H, Stone GW, Antoniucci D, Biondi-Zoccai G, Kastrati A, etc. Coronary stenting and balloon angioplasty for acute myocardial infarction: Meta regression analysis of a randomized trial[J]. Int J glycol. 2008; 126(1):37-44. https://doi.org/10.1016/j.ijcard.2007.03.112. Wang HR, Zhang CP, Wang Z, Zhang M, Zhao L. Clinical application and research status of drug-coated balloon in percutaneous coronary intervention. Chinese Medical Journal. 2019;10:1583-6. Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, etc. 2018 ESC / EACTS Myocardial Revascularization Guidelines. Eur Heart J. 2019;40(2):87–165. https://doi.org/10.1093/eurheartj/ehy394 . Holmvang L, Kelbk H, Kaltto A, Thuesen L, Lassen JF, Clemmensen P, etc. Long-term results of ST-segmengt elevated myocardial infarction after the patient’s drug-eluting and bar psychological stent implantation: 5-year follow-up from random intermittent injection of CA TI (drug elution and distal protection for acute myocardial infarction) to titanium aluminum alloy. JACC Cardiovascular Intervention 2013;6960:548–53. Indermuehle A, Bahl R, Lansky AJ, Froehlich GM, Knapp G, Timmis A, etc. Drug-eluting balloon angioplasty for stent restenosis: a systematic view and a meta-analysis of randomized controlled trials. heart. 2013;99(5):327-33. https://doi.org/10.1136/heartjnl-2012-302945 . Posa A, Nyolczas N, Hemetsberger R, Pavo N, Penethazy O, Petrasi Z, etc. Optimizing the safety and effectiveness of drug-eluting balloons: Evaluation of the second-generation Paclitaxel-eluting porcine coronary DIOR balloon. Catheter cardiovascular interventional therapy. 2010;76(3):395-403. https://doi.org/10.1002/ccd.22468. Finn AV, Nakazawa KG, Joner M, Kolodgie FD, Mont EK, Gold HK, etc. Vascular response to drug-eluting stents: the importance of delayed healing. Arterial Thromboembolism Vascular Biology. 2007;27(7):1500-10. https://doi.org/10.1161/ATVBAHA.107.144220 . Yazdani SK, Pacheco E, Nakanookinetic M, Kolodgie FD, Mont EK, Gold HK, etc. The downstream of the blood vessel in the porcine femoral artery model and the pharmacokinetic response of the low-dose drug-coated balloon to the drug treatment. Catheter cardiovascular interventional therapy. 2014;83(1):132–40. https://doi.org/10.1002/ccd.24995. Windecker S, Kolh P. 2014 ESC/EATS Myocardial Revascularization Guidelines: The European Society of Cardiology (ESC) and the European Association of Cardiothoracic Surgery (EACT S)’s Myocardial Revascularization Task Force in the European Association for Percutaneous Cardiovascular Intervention (EAPC) I). Eur Heart J. 2014;35(37):2541-619. https://doi.org/10.1093/eurheartj/ehu278. Belkacemi A, Agostoni P, Nathoe HM, Voskuil M, Shao C, Belle EV, etc. Preliminary results of DEB-AMI (Acute ST-segment drug-eluting balloon-segment level elevation myocardial infarction) test: In the case of initial percutaneous coronary intervention and 6-month angiography, the drug-eluting balloon Multi-center random comparison of purulent bare metal stents and drug-eluting stents, intravascular function and clinical results. J Am Coll Cardiol. 2012;59(25):2327-37. https://doi.org/10.1016/j.jacc.2012.02.027 . Chinese Society of Cardiovascular Diseases, Chinese Medical Association, "Chinese Journal of Cardiovascular Diseases" Editorial Board. Guidelines for the diagnosis and treatment of acute ST-segment elevation myocardial infarction. Chinese Journal of Cardiovascular Disease 2015;43:380–93. Cremers B, TonerJ L, Schwartz LB, Oepen RO, Speck U, Kaufels N, etc. Inhibition of neointimal hyperplasia by new-type zotalimus-coated balloon catheter. Clinical Res Cardiol. 2012;101(6):469-76. https://doi.org/10.1007/s00392-012-0415-7. Wohrle J, Zadura M, Mobius-WinkIer S, Leschke M, Opitz C, Ahmed W, etc. Subsequent global registration study: clinical results "subsequent to a large-scale, prospective registration study of paclitaxel-coated balloon angioplasty". J Am Coll Cardjol. 2012;60(18):1733-8. https://doi.org/10.1016/j.jacc.2012.07.040. López Mínguez JR, Nogales Asensio JM, Doncel Vecino LJ, Sandoval J, Romany S, Romero PM, etc. Prospective randomized study of paclitaxel-coated balloon catheter in the treatment of coronary artery bifurcation lesions (BABILON trial): 24-month clinical and angiographic results. Euro exchange rate. 2014;10(1):50-7. https://doi.org/10.4244/EIJV10I1A10. Higuma T, Soeda T, Abe N, Yamada M, Yokoyama H, Shibutani S, etc. The study of the combination of optical coherence tomography and intravascular ultrasound on plaque rupture, plaque erosion and calcified nodules in patients with ST-segment elevation myocardial infarction: the incidence, morphological characteristics and outcome after percutaneous coronary intervention. JACC Cardiovascular Intervention 2015;8(9):1166-76. https://doi.org/10.1016/j.jcin.2015.02.026. Wang Shan, Li DB. Research progress on the role of drug-coated balloons in acute ST-segment elevation myocardial infarction. Chinese Journal of Evidence-Based Medicine. 2018;10:1434-5. Jeger RV, Eccleshall S, Wan Ahmad WA, Ge JB, Poerner TC, Shin ES, etc. Drug-coated balloons for coronary artery disease: the third report of the International DCB Consensus Group[J]. JACC Cardiovascular Intervention 2020; 13(12):1391-402. https://doi.org/10.1016/j.jcin.2020.02.043 . Yu X, Ji F, Xu F, Zhang Wande, Wang Xinxi, Lu D, etc. Using only paclitaxel-coated balloons to treat de novo large coronary artery disease: results from a research institution in China. Clinical Res Cardiol. 2019;108(3):234–43. https://doi.org/10.1007/s00392-018-1346-8 . Magalhaes MA, Minha S, Chen F, Torguson R, Omar AF, Loh JP, etc. The clinical manifestations of the third-generation stent and the results of in-stent restenosis of the coronary artery. Circ Cardiovascular Intervention 2014;7(6):768-76. https://doi.org/10.1161/CIRCINTERVENTIONS.114.001341. Paramasivam G, Devasia T, Ubaid S, Shetty A, Nayak K, Pai U, etc. In-stent restenosis of drug-eluting stents: clinical manifestations and results in the real world. Heart of Egypt J.2019;71(1):28. https://doi.org/10.1186/s43044-019-0025-z. Jeger RV, Farah A, Ohlow MA, Mangner N, Möbius-WinklerS, Weilenmann D, etc. Long-term efficacy and safety of drug-coated balloons compared with drug-eluting stents in small coronary artery disease (BASKET-SMAL L 2): Three-year follow-up of a randomized, non-inferiority trial. Lancet. 2020;396(10261):1504-10. https://doi.org/10.1016/S0140-6736(20)32173-5. Axel DI, Kunert W, Gggelmann C, Oberhoff M, Herdeg C, Küttner A, etc. Paclitaxel inhibits the proliferation and migration of arterial smooth muscle cells in vitro and in vivo through local drug delivery. cycle. 1997;96(2):636-45. https://doi.org/10.1161/01.CIR.96.2.636 . Pan YY, Zhang Feng. The application progress of drug-eluting balloons in stent restenosis after percutaneous coronary intervention. Chinese Journal of Clinical Medicine 2018;133:161-6. Fang CY, Fang HY, Chen CJ, Yang CH, Wu CJ, Li WC. Comparison of clinical outcomes after in-stent restenosis-related acute myocardial infarction with drug-eluting balloon and drug-eluting stent: a retrospective study. Peer J. 2018;(6):e4646. Wang Hongxun. Efficacy and safety evaluation of paclitaxel-coated balbon in the treatment of restenosis in drug-eluting stents. Inner Mongolia Medical University. 2018. Dorenkamp M, Boldt J, Leber AW, Sohns C, Roser M, Boldt LH, etc. Cost-effectiveness of paclitaxel-coated balloon angioplasty in patients with drug-eluting stent restenosis. Clinical Cardiolo. 2013;36(7):407-13. https://doi.org/10.1002/clc.22130.